Toxicology
April 21, 2026
Harriet Kamendi, PhD, DABT I design FDA evidence that protects capital · Regulatory Toxicologist, PhD DABT · Medical Devices · Diagnostics · Drugs · Biologics · […]
April 17, 2026
A founder says the company has a regulatory roadmap. The slide looks polished.
The milestones look neat.
The dates seem aggressive, but still believable. An investor flips through it and thinks one thing: Can I trust this? That is the real test.
April 15, 2026
The timeline looked brilliant. Prototype by June.Verification by September.FDA meeting by November.Submission next year. Clean. Sharp. Reassuring. Then reality showed up. One design change delayed testing.A […]
April 14, 2026
Everything looks fine until FDA responds. The roadmap is on track. The milestones are moving. The team is hitting deadlines. Then the feedback arrives. FDA wants […]
